---
layout: post
title: "Certain Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same; Notice of Institution of Investigation"
date: 2026-02-05 18:57:54 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-01917
original_published: 2022-01-31 00:00:00 +0000
significance: 8.00
---

# Certain Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same; Notice of Institution of Investigation

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** January 31, 2022 00:00 UTC
**Document Number:** 2022-01917

## Summary

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on December 17, 2021, under section 337 of the Tariff Act of 1930, as amended, on behalf of AbbVie Inc. of Chicago, Illinois; AbbVie Biotechnology Ltd. of Bermuda; and AbbVie Operations Singapore Pte. Ltd. of Singapore. A supplement to the complaint was filed on January 4, 2022. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States and the sale of certain adalimumab, processes for manufacturing or relating to same, and products containing same by reason of the misappropriation of trade secrets and tortious interference with contractual relations, the threat or effect of which is to destroy or substantially injure an industry in the United States. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/01/31/2022-01917/certain-adalimumab-processes-for-manufacturing-or-relating-to-same-and-products-containing-same)
- API: https://www.federalregister.gov/api/v1/documents/2022-01917

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
